Effects of Glucagon Administration on Energy Expenditure

NCT02237053 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

6

Enrollment

OTHER

Sponsor class

Conditions

Hyperglucagonemia
Obesity

Interventions

DRUG: Glucagon
DRUG: Octreotide
BEHAVIORAL: Placebo
DRUG: Insulin

Sponsor

AdventHealth Translational Research Institute